Search

Your search keyword '"Sharma, Akshay"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Sharma, Akshay" Remove constraint Author: "Sharma, Akshay" Publisher elsevier bv Remove constraint Publisher: elsevier bv
109 results on '"Sharma, Akshay"'

Search Results

1. International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced

3. Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study

4. Real World Use of the Pediatric Disease Risk Index for Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: A Multicenter Study

5. Survey of Infection Surveillance, Prophylaxis, and Vaccination Practices after Autologous Genetically Modified Cellular Therapies

6. Elimination of Vaso-Occlusive Crises after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

7. Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

8. Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease

10. Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond

11. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy

12. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis

13. Incidence and impact of fungal infections in post-transplant Cyclophosphamide (PTCy)-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: A CIBMTR analysis

15. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission

17. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors

18. International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant

20. Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines

21. Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers

24. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia

27. Machine Learning Approaches Incorporating High-Dimensional Longitudinal Data Improve Survival Prediction after Allogeneic Hematopoietic Cell Transplantation

28. Second Allogeneic HCT Can Successfully Salvage a Subset of Patients Who Relapse Following First Allogeneic HCT: A Single-Center Retrospective Analysis of 108 Pediatric Patients

29. Impact of Trimethoprim/Sulfamethoxazole Prophylaxis on Engraftment in Pediatric Hematopoietic Cell Transplant Recipients

33. Impact of Public Reporting of Center-Specific Analysis Scores on Hematopoietic Cell Transplant Center Volumes

34. Early Lymphocyte Immune Reconstitution As Predictor for Outcomes after Allogeneic Hematopoietic Cell Transplantation for Malignant Indications; A Tri-Institutional Analysis

35. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering

36. 3045 – SICKLE CELL DISEASE COMPROMISES THE HEMATOPOIETIC STEM CELL BONE MARROW NICHE WITH AGE

40. Telehealth in Neurosurgery: 2021 Council of State Neurosurgical Societies National Survey Results

42. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy

44. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study

45. Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment

46. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials

48. Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation

49. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

50. CD45RA Depleted T-Cell Addback and Prophylactic Blinatumomab Administration Following Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia

Catalog

Books, media, physical & digital resources